Amgen (AMGN) Cash from Operations (2009 - 2026)

Amgen (AMGN) has reported Cash from Operations for 18 consecutive years, with 2189000000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Operations rose 57.37% year-over-year to 2189000000.0; the TTM figure through Mar 2026 stood at 10756000000.0 (down 11.78% YoY), while the FY2025 annual figure was 9958000000.0, down 13.33% from the prior year.
• Cash from Operations came in at 2189000000.0 for Q1 2026 at Amgen, up from 1603000000.0 in the prior quarter.
• The five-year high for Cash from Operations was 4771000000.0 in Q4 2024, with the low at 538000000.0 in Q4 2023.
• Average Cash from Operations over 5 years is 2460529411.76, with a median of 2280000000.0 recorded in 2025.
• Across the five-year window, Cash from Operations tumbled 79.69% in 2023 and jumped 786.8% in 2024, its largest moves.
• Year by year, Cash from Operations stood at 2649000000.0 in 2022, then sank by 79.69% to 538000000.0 in 2023, then surged by 786.8% to 4771000000.0 in 2024, then sank by 66.4% to 1603000000.0 in 2025, then jumped by 36.56% to 2189000000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 2189000000.0, 1603000000.0, and 4684000000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.